INS and type 1 diabetes mellitus: The development and evolution of diabetes technology over the past 20 years, including insulin pumps, continuous glucose monitors (CGMs), and artificial insulin delivery (AID) systems, have revolutionized diabetes care and resulted in improved HbA1c, time in range (TIR), rates of hypoglycemia, and quality of life among people with insulin-dependent diabetes [1–4].